In this video, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses the key differences between current adult and pediatric health care models, and more.
Dr Cohen reviews his presentation from the July 25 AIBD regional meeting on using biosimilars as first-line and switch therapy in patients with inflammatory bowel disease.